Lynn Sage Breast Cancer Symposium | Conferences

New Treatment Paradigm Required for Breast Cancer in Young Women

September 17, 2017

Younger women with breast cancer, which make up of around 20% of patients, present with unique disease characteristics that warrant careful consideration of potentials treatments, particularly given the potential for long-term side effects.

Breast Cancer Genome to Shape Precision Medicine

September 16, 2017

As the breast cancer genome continues to be unraveled, a host of new targetable alterations outside of HER2 and the estrogen receptor are beginning to emerge, providing the exciting potential for development of new therapies.

Determining the Risk Associated With Mutations Identified From Multigene Testing

September 16, 2017

Figuring out how a certain genetic result found through multigene testing might change not only the type of intervention but its timing is the chief challenge, according to Mark Robson, MD, in a presentation at the 2017 Lynn Sage Breast Cancer Symposium.